Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/29/2009US20090270427 Purine derivatives
10/29/2009US20090270426 P13 Kinase Antagonists
10/29/2009US20090270425 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
10/29/2009US20090270424 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrochloride
10/29/2009US20090270423 Antibacterial small molecules and methods for their synthesis
10/29/2009US20090270422 treating osteoporosis, rheumatoid arthritis, osteoarthritis, periodontal disease, alveolar bone loss, osteotomy bone loss, childhood idiopathic bone loss, Paget's disease, bone loss due to metastatic cancer, osteolytic lesions, using GPR119 agonist in combination with dipeptidyl peptidase IV inhibitor
10/29/2009US20090270421 Inhibitors of fatty acid amide hydrolase
10/29/2009US20090270420 Methods for inhibiting cardiac pai-1
10/29/2009US20090270419 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
10/29/2009US20090270418 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
10/29/2009US20090270417 Organic Compounds
10/29/2009US20090270416 N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER
10/29/2009US20090270415 Compounds that inhibit protease cathepsin s and hcv replication
10/29/2009US20090270414 2,3,4,9- tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
10/29/2009US20090270413 Di-t-butylphenyl piperazines as calcium channel blockers
10/29/2009US20090270412 Pyrido[3,4-b]indoles and methods of use
10/29/2009US20090270411 Phenanthridine derivatives as bradykinin antagonists
10/29/2009US20090270410 Benzazole analogues and uses thereof
10/29/2009US20090270409 Compounds and compositions as modulators of gpr119 activity
10/29/2009US20090270408 Amide derivatives as positive allosteric modulators and methods of use thereof
10/29/2009US20090270406 Combination Therapy for the Treatment of Urinary Frequency, Urinary Urgency and Urinary Incontinence
10/29/2009US20090270405 nicotinic receptor ligands such as N-(benzo[d]thiazol-2-yl)-4H-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octan]-2-amine, used for the treatment of nervous system, psychological and neurodegenerative disorders; treatment of schizophrenia or Alzheimer's Disease
10/29/2009US20090270404 Oxymethylene aryl compounds and uses thereof
10/29/2009US20090270403 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
10/29/2009US20090270402 Novel triazolopyridazines
10/29/2009US20090270401 Use of a dihydroimidazopyrazoine derivative for treating or preventing pain
10/29/2009US20090270400 Painkilling association comprising a dihydroimidazopyrazine derivative
10/29/2009US20090270399 Novel pyridazine derivatives and medicines containing the same as effective ingredients
10/29/2009US20090270398 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/29/2009US20090270397 Methods and compositions for the treatment of cancers, such as melanomas and gliomas
10/29/2009US20090270396 Therapeutic compounds
10/29/2009US20090270395 EP4 Receptor Agonist, Compositions and Methods Thereof
10/29/2009US20090270394 Cyclylamine derivatives as calcium channel blockers
10/29/2009US20090270393 Iminopyridine Derivatives and Use Thereof
10/29/2009US20090270392 prostaglandin EP2 receptor agonists for treating baldness, glaucoma, post-surgical and post-laser trabeculectomy ocular hypertensive episodes, inflammatory bowel disease, and as presurgical adjuncts
10/29/2009US20090270391 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY
10/29/2009US20090270390 Pyrimidine derivatives
10/29/2009US20090270389 Pyrimidinyl pyridone inhibitors of kinases
10/29/2009US20090270388 Fused azole-pyrimidine derivatives
10/29/2009US20090270387 Substituted arylcyclopentenes as therapeutic agents
10/29/2009US20090270386 Therapeutic compounds
10/29/2009US20090270385 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
10/29/2009US20090270384 Morpholine dopamine agonists
10/29/2009US20090270383 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270381 Non-steroidal progesterone receptor modulators
10/29/2009US20090270380 3,4,5-Substituted Piperidines as Renin Inhibitors
10/29/2009US20090270379 Quinolone derivatives useful as antibacterial agents
10/29/2009US20090270378 Novel tetrahydropyridothiophenes
10/29/2009US20090270377 Combination cancer chemotherapy
10/29/2009US20090270376 Heterocyclic janus kinase 3 inhibitors
10/29/2009US20090270375 Spiro antibiotic derivatives
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/29/2009US20090270373 Treatment of down syndrom with benzodiazepine receptor antagonists
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270371 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
10/29/2009US20090270370 Fused heterocyclic compounds
10/29/2009US20090270369 Bicycloamine derivatives
10/29/2009US20090270368 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270366 Benzoimidazole compounds
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270364 Substituted pyrimidine derivatives
10/29/2009US20090270363 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
10/29/2009US20090270362 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
10/29/2009US20090270361 Substituted pyrazole derivatives and use thereof
10/29/2009US20090270360 Dicarboxamide derivatives
10/29/2009US20090270359 Substituted pyrazole derivatives
10/29/2009US20090270358 Pharmaceutical formulation of clavulanic acid
10/29/2009US20090270356 Compositions and treatments of heart failure in non-human mammal animals
10/29/2009US20090270355 Compounds
10/29/2009US20090270354 Method of removing ticks from the skin and reducing the risk of bites
10/29/2009US20090270353 Compounds for the treatment of proliferative disorders
10/29/2009US20090270352 Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
10/29/2009US20090270351 Phosphorus derivatives as histone deacetylase inhibitors
10/29/2009US20090270350 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives
10/29/2009US20090270348 Sulfoalkyl Ether Cyclodextrin Compositions
10/29/2009US20090270347 Methods of producing microparticles
10/29/2009US20090270346 Protective gel based on chitosan and oxidized polysaccharide
10/29/2009US20090270345 Polymeric artificial tear system
10/29/2009US20090270344 Structure and bioactivity of the polysaccharides and oligomers in medicinal plant Dendrobium huoshanense
10/29/2009US20090270343 Polysaccharide Extract of Lentinus and Pharmaceutical, Cosmetic or Nutraceutical Compositions Comprising Such an Extract
10/29/2009US20090270342 Immunoregulatory agent
10/29/2009US20090270341 Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer
10/29/2009US20090270340 Methods of administering antitumor agent comprising deoxycytidine derivative
10/29/2009US20090270339 Unit Dose Form of Glufosfamide
10/29/2009US20090270336 Piperazine derivatives
10/29/2009US20090270332 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/29/2009US20090270326 Cell Death Inhibitor
10/29/2009US20090270310 Process for the preparation of a nutrient formulation
10/29/2009US20090270308 Controlled release implantable dispensing device and method
10/29/2009US20090269795 Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269427 Herbal composition for inflammatory disorders
10/29/2009US20090269426 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
10/29/2009US20090269421 Coating material
10/29/2009US20090269420 Substituted dihydropyrazolones and their use
10/29/2009US20090269418 Compositions and Methods for Inducing Hair Growth
10/29/2009US20090269417 Thiolated chitosan gel
10/29/2009US20090269412 Pharmaceutical formulations for dry powder inhalers
1 ... 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 ... 7860